In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The findings suggest that the treatment may work as an add-on therapy to ...

The clinical syndrome produced by a stroke is determined by the artery ... The vertebrobasilar system supplies the brainstem and has branches to the cerebellum. The basilar artery typically ...

The other type of ischemic stroke is a thrombotic stroke ... oxygenated blood may not reach the occipital lobes, brainstem, and cerebellum—areas that control functions like breathing, sight ...

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

The cerebral cortex processes conscious information, while the brain stem is the connection ... in the brain. Strokes are generally classified into two types: ischemic and hemorrhagic.

A clot-dissolving tissue plasminogen activator (tPA), tenecteplase is now indicated for acute ischemic stroke on top of its older approval in acute ST-elevation myocardial infarction. Tenecteplase ...

Hypertension is the most important modifiable risk factor for ischemic stroke, and antihypertensive treatment is of paramount importance to reduce the incidence of stroke mortality and morbidity.

Mini stroke, also known as a transient ischemic attack (TIA) is a short period of symptoms that are similar to that of a stroke. It is like a temporary stroke wherein there's a temporary lack of ...

The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according to the manufacturer. Genentech said in a press release that TNKase ...